IVI holds international vaccinology course in Seoul for professionals
By Alexander Ahn
The International Vaccine Institute (IVI), the world’s only international organization devoted to developing vaccines for the world’s poor, kicked off its “12th International Advanced Course on Vaccinology in the Asia-Pacific Region” Monday for a weeklong run at its headquarters at Seoul National University in Seoul.
The highly acclaimed course was the first established for vaccinology in the Asia-Pacific region. It aims to help health professionals build their knowledge in all areas of the vaccine spectrum from development and evaluation to production and policy. Participants will discuss adult vaccines, ethical consideration in vaccine studies and communication strategies.
Over 90 professionals from 27 countries are enrolled.The participants consist of scientists, public health officials and policymakers from both the private and public sectors.
The course is designed to help improve the ability of developing country professionals and other participants to develop and evaluate safe, high quality vaccines.
Lectures by leading specialists in vaccinology, roundtable discussions, and interactive case studies will be conducted on a wide range of disciplines, including epidemiology and immunology, vaccine technology, regulatory issues, and vaccine economics and financing.
Established as an initiative of the United Nations Development Program in 1997, IVI operates as an independent international organization under a treaty signed by 40 countries and the World Health Organization. The institute conducts research in more than 30 countries in Asia, Africa and Latin America on vaccines against diarrheal infections, bacterial meningitis and pneumonia, as well as Japanese encephalitis and dengue fever, and develops new and improved vaccines at its headquarters in Seoul. For more information, visit www.ivi.int.